Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy causes hair loss in cancer patients by affecting both growing and resting hair.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

YH0618 granule may help prevent hair loss in breast cancer patients undergoing chemotherapy.

YH0618 granules may help prevent hair loss in breast cancer patients undergoing chemotherapy.

YH0618 granules may help prevent hair loss in breast cancer patients undergoing chemotherapy.

YH0618 granules may help prevent hair loss in breast cancer patients undergoing chemotherapy.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

Medulla loss in scalp hair could help detect breast cancer.

Chemotherapy for breast cancer often causes significant and lasting hair loss.

Scalp cooling therapy helps preserve hair during chemotherapy for most patients.

The trial will test if YH0618 granule prevents hair loss in breast cancer patients during chemotherapy.

Taxane-based chemotherapy causes more hair loss and skin changes in Asian breast cancer patients.

A scalp-cooling system effectively prevents hair loss in breast cancer patients treated with eribulin.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Consult an oncologist before using supplements for hair loss during breast cancer treatment.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Cinnamon bark extract may help prevent weight loss and hair loss in breast cancer patients during chemotherapy and is safe to use.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Hair and scalp pain is more common and severe in breast cancer patients on chemotherapy than those on tamoxifen.

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.

Permanent hair loss from chemotherapy significantly impacts patients' mental health and social life, highlighting the need for better patient education and support.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Some breast cancer treatments, like taxanes, can cause long-term hair loss.

Tamoxifen caused hair loss in a 52-year-old woman.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

Oncologists should better understand the unique impact of hair loss on Black breast cancer patients to offer more compassionate care.

Alopecia areata causes significant psychological distress in cancer patients, needing integrated care.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Hair transplant surgeons should also focus on their patients' overall health, including regular check-ups and screening for common health issues.

Dermatologists should carefully manage hair loss in cancer patients to improve their quality of life.